| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1448.011 |
| P698 | PubMed publication ID | 18837943 |
| P2093 | author name string | Eiji Sunami | |
| Dave S B Hoon | |||
| Sandy L Nguyen | |||
| Armando E Giuliano | |||
| Anh-Thu Vu | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 171-174 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. | |
| P478 | volume | 1137 |
| Q36286368 | Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment |
| Q39344296 | Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. |
| Q55103792 | Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? |
| Q38002456 | Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content |
| Q34184393 | Cell-free nucleic acids as biomarkers in cancer patients |
| Q52721890 | Centrifugation-free extraction of circulating nucleic acids using immiscible liquid under vacuum pressure. |
| Q36712146 | Chromatin immunoprecipitation and gene expression analysis of neuronal subtypes after fluorescence activated cell sorting |
| Q91893726 | Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine |
| Q35748716 | Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer |
| Q45799429 | Circulating cell-free DNA in serum as a biomarker of colorectal cancer. |
| Q87930863 | Circulating tumor DNA measurement provides reliable mutation detection in mice with human lung cancer xenografts |
| Q35125657 | Circulating tumour markers can define patients with normal colons, benign polyps, and cancers |
| Q38800475 | Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology |
| Q38154781 | Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer |
| Q41787211 | Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer |
| Q38152782 | Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. |
| Q44158160 | Diagnostic relevance of plasma DNA and DNA integrity for breast cancer |
| Q42546251 | Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. |
| Q37385238 | Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q26738567 | Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors |
| Q38249332 | Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance |
| Q34086617 | Improved blood tests for cancer screening: general or specific? |
| Q85012315 | Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia |
| Q33886421 | LINE-1 hypomethylation during primary colon cancer progression |
| Q38871132 | Liquid Biopsies in Oncology and the Current Regulatory Landscape |
| Q35184508 | Mobilization of LINE-1 in irradiated mammary gland tissue may potentially contribute to low dose radiation-induced genomic instability |
| Q64054307 | Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA) |
| Q89967718 | Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection |
| Q46790693 | Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer |
| Q89111227 | Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastoma |
| Q90057486 | Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics |
| Q92235375 | Predictive value of the serum RASSF10 promoter methylation status in gastric cancer |
| Q90487732 | Quantification of plasma cell-free DNA levels in dogs with various tumors |
| Q36557527 | RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb |
| Q26861681 | Recent advances in clinical applications of circulating cell-free DNA integrity |
Search more.